articleEuropean Journal of ImmunologyApr 13, 2005BRONZE OA

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway

University of Genoa

PubMed
Indexed incrossrefpubmed

Abstract

Bone marrow mesenchymal progenitor cells (BMSC) are used for regenerating tissues of mesodermal origin, as well as tissues of different embryological derivation. Experimental evidence shows that BMSC are able to suppress the activation of the immune response by mechanisms that are still not completely understood. Thus far, in vitro studies carried using human or mouse cells indicate that autologous or allogeneic BMSC strongly suppress proliferation of T lymphocytes, triggered by cellular stimuli, nonspecific mitogenic stimuli, or antigenic peptides. Using cell proliferation and blocking assays, we demonstrated that BMSC inhibited the activation of murine splenocytes, T, and B lymphocytes. Direct contact of…

Citation impact

689
total citations
FWCI
8.82
Percentile
100%
References
32
Citations per year

Authors

7

Topics & keywords

Keywords
  • Biology
  • Cell biology
  • Mesenchymal stem cell
  • Bone marrow
  • Progenitor cell
  • Cytokine
  • Immune system
  • Immunology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.